Follow
Sascha Kiesslich
Sascha Kiesslich
Verified email at mail.mcgill.ca
Title
Cited by
Cited by
Year
Vero cell upstream bioprocess development for the production of viral vectors and vaccines
S Kiesslich, AA Kamen
Biotechnology advances 44, 107608, 2020
1012020
A Review of Process-Design Challenges for Industrial Fermentation of Butanol from Crude Glycerol by Non-Biphasic Clostridium pasteurianum
T Sarchami, G Munch, E Johnson, S Kießlich, L Rehmann
Fermentation 2 (2), 13, 2016
572016
Serum-free production of rVSV-ZEBOV in Vero cells: Microcarrier bioreactor versus scale-X™ hydro fixed-bed
S Kiesslich, JPVC Losa, JF Gélinas, AA Kamen
Journal of biotechnology 310, 32-39, 2020
322020
Production of rVSV-ZEBOV in serum-free suspension culture of HEK 293SF cells
JF Gélinas, H Azizi, S Kiesslich, S Lanthier, J Perdersen, PS Chahal, ...
Vaccine 37 (44), 6624-6632, 2019
312019
Consolidating biofuel platforms through the fermentative bioconversion of crude glycerol to butanol
E Johnson, T Sarchami, S Kießlich, G Munch, L Rehmann
World Journal of Microbiology and Biotechnology 32, 1-14, 2016
272016
Bioreactor production of rVSV‐based vectors in Vero cell suspension cultures
S Kiesslich, GN Kim, CF Shen, CY Kang, AA Kamen
Biotechnology and bioengineering 118 (7), 2649-2659, 2021
242021
Process development for Newcastle disease virus-vectored vaccines in serum-free vero cell suspension cultures
JPC Fulber, O Farnós, S Kiesslich, Z Yang, S Dash, L Susta, SK Wootton, ...
Vaccines 9 (11), 1335, 2021
192021
Haplotype-resolved de novo assembly of the Vero cell line genome
MA Sène, S Kiesslich, H Djambazian, J Ragoussis, Y Xia, AA Kamen
npj Vaccines 6 (1), 106, 2021
192021
Titration methods for rVSV-based vaccine manufacturing
JF Gélinas, S Kiesslich, R Gilbert, AA Kamen
MethodsX 7, 100806, 2020
172020
Pervaporative butanol removal from PBE fermentation broths for the bioconversion of glycerol by Clostridium pasteurianum
S Kießlich, T Sarchami, G Munch, K Gao, L Rehmann, W Kujawski, ...
Journal of membrane science 535, 79-88, 2017
152017
Temporal characterization of protein production levels from baculovirus vectors coding for GFP and RFP genes under non‐conventional promoter control
S George, AM Jauhar, J Mackenzie, S Kieβlich, MG Aucoin
Biotechnology and bioengineering 112 (9), 1822-1831, 2015
152015
Evaluation of novel HIV vaccine candidates using recombinant vesicular stomatitis virus vector produced in serum-free Vero cell cultures
M Mangion, JF Gélinas, ABZ Gashti, H Azizi, S Kiesslich, N Nassoury, ...
Vaccine 38 (50), 7949-7955, 2020
132020
Genomics of Vero Cells: Understanding this Cell Line and its Virus-Host Interactions for Improved Vaccine Production
MA Sene
McGill University (Canada), 2022
2022
Bioreactor production of rVSV-vectored vaccines in Vero cell suspension cultures
S Kiesslich, G Kim, CF Shen, CY Kang, A Kamen
Authorea Preprints, 2021
2021
Development of a Vero cell platform for rVSV vector production
S Kiesslich
McGill University (Canada), 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–15